Literature DB >> 34280390

SIRT5's GOT1 up on PDAC.

Surinder Kumar1, David B Lombard2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34280390      PMCID： PMC8545847          DOI： 10.1053/j.gastro.2021.07.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  19 in total

Review 1.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

2.  SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.

Authors:  Xin Yang; Zhe Wang; Xin Li; Boya Liu; Minghui Liu; Lu Liu; Shuaiyi Chen; Mengmeng Ren; Yankun Wang; Miao Yu; Bo Wang; Junhua Zou; Wei-Guo Zhu; Yuxin Yin; Wei Gu; Jianyuan Luo
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

3.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

Authors:  Brian J North; Brett L Marshall; Margie T Borra; John M Denu; Eric Verdin
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

4.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

5.  SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancer.

Authors:  Xiu-Fei Chen; Meng-Xin Tian; Ren-Qiang Sun; Meng-Li Zhang; Li-Sha Zhou; Lei Jin; Lei-Lei Chen; Wen-Jie Zhou; Kun-Long Duan; Yu-Jia Chen; Chao Gao; Zhou-Li Cheng; Fang Wang; Jin-Ye Zhang; Yi-Ping Sun; Hong-Xiu Yu; Yu-Zheng Zhao; Yi Yang; Wei-Ren Liu; Ying-Hong Shi; Yue Xiong; Kun-Liang Guan; Dan Ye
Journal:  EMBO Rep       Date:  2018-02-28       Impact factor: 8.807

6.  SIRT5 desuccinylates and activates SOD1 to eliminate ROS.

Authors:  Zhi-Feng Lin; Hong-Bing Xu; Jian-Yun Wang; Qiang Lin; Zhen Ruan; Fa-Bing Liu; Wang Jin; Hai-Hua Huang; Xi Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-10-16       Impact factor: 3.575

Review 7.  Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.

Authors:  Surinder Kumar; David B Lombard
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04-11       Impact factor: 8.250

Review 8.  Harnessing metabolic dependencies in pancreatic cancers.

Authors:  Joel Encarnación-Rosado; Alec C Kimmelman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-03-19       Impact factor: 46.802

9.  The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics.

Authors:  William Giblin; Lauren Bringman-Rodenbarger; Angela H Guo; Surinder Kumar; Alexander C Monovich; Ahmed M Mostafa; Mary E Skinner; Michelle Azar; Ahmed Sa Mady; Carolina H Chung; Namrata Kadambi; Keith-Allen Melong; Ho-Joon Lee; Li Zhang; Peter Sajjakulnukit; Sophie Trefely; Erika L Varner; Sowmya Iyer; Min Wang; James S Wilmott; H Peter Soyer; Richard A Sturm; Antonia L Pritchard; Aleodor A Andea; Richard A Scolyer; Mitchell S Stark; David A Scott; Douglas R Fullen; Marcus W Bosenberg; Sriram Chandrasekaran; Zaneta Nikolovska-Coleska; Monique E Verhaegen; Nathaniel W Snyder; Miguel N Rivera; Andrei L Osterman; Costas A Lyssiotis; David B Lombard
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 14.808

Review 10.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.

Authors:  Michael Orth; Philipp Metzger; Sabine Gerum; Julia Mayerle; Günter Schneider; Claus Belka; Maximilian Schnurr; Kirsten Lauber
Journal:  Radiat Oncol       Date:  2019-08-08       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.